The short answer
Review hops before adding it to oxazepam. Preparation-specific alertness effects are possible, but exact co-use evidence does not establish a universal sedation or separation rule.
What this answer covers
Oral Humulus lupulus female inflorescence preparations; other plant parts or mixtures are not equivalent.
- Supplement or preparation
- Humulus lupulus
- Medication ingredient
- oxazepam
What guidance actually says
Hops monograph describes traditional sleep-aid use and possible driving impairment, while listing no reported interactions.
What the human study adds
One standardized hop extract had no clinically relevant CYP probe effect in a small study. This did not test sedation or oxazepam, whose major metabolite is a glucuronide.
Bring the product details
Show the pharmacist the species, plant part, extract and other active ingredients. No protective number of hours between this product and oxazepam has been demonstrated.
Protect your alertness
Oxazepam can impair coordination and alertness. Avoid driving when affected. Seek urgent help for severe difficulty waking or breathing, and tell the prescriber about all other sedating medicines and alcohol.
Evidence and practical considerations
Side effects & toxicity
A cautious product review is sensible; broad exact-pair sedation and avoidance claims remain insufficient.
- Exact scope
- Oral Humulus lupulus female inflorescence preparations; other plant parts or mixtures are not equivalent. with Exact oral oxazepam; no blanket benzodiazepine metabolic or route transfer.
- Medication form and route
- oral; other cannabis routes only if explicitly discussed
- Timing or duration
- Exact duration and dose depend on source; single-dose and chronic use are distinguished.
What remains uncertain
- No exact oxazepam co-use study. Traditional sleep use, other-drug PK results and acute extract effects cannot quantify combined impairment.
Factors that may matter: preparation and plant part; dose; other medicines; baseline alertness; clinical indication.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral oxazepam.
CNS depression, impaired coordination and alertness can occur; concomitant CNS depressants require caution. Dependence and withdrawal risks require individualized tapering rather than abrupt cessation. A single major inactive glucuronide metabolite is excreted in urine. CYP3A interactions measured with alprazolam cannot simply be assigned to oxazepam.
How this applies: Exact RxNorm ingredient and oral formulation confirmed in original label; use exact indication and metabolic boundaries.
Does not quantify the requested botanical interaction risks, prove every herb is sedating, or establish a protective supplement interval.
Source 2: official herbal monograph
ema.europa.eu · Source check Sep 10, 2026
Population: Users of specified oral herbal preparations.
Traditional use for mild stress and aiding sleep; may impair driving. No interactions reported.
How this applies: Supports preparation-specific caution; does not establish additive sedation with the requested drug.
Traditional use is not proof of exact drug interaction. Part/extract boundaries and absence of clinical co-use data remain.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Sixteen peri/postmenopausal women.
No clinically relevant CYP probe interaction; alprazolam AUC declined slightly rather than showing inhibition.
How this applies: Apply only to exact medication, preparation and study exposure; comparator treatment is not co-use.
Other medications and metabolic endpoints, not temazepam/oxazepam or additive sedation; absence of PK interaction is not absence of impairment.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current exact claims adjudicated against captured originals and explicit comparator/co-use boundaries. | |
| Research summary published |
Article revision: a2a0d71287a27c9a
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.